Emerging Therapies for Dystrophic Cardiomyopathy

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)792-794
Number of pages3
JournalJACC: Basic to Translational Science
Volume4
Issue number7
DOIs
StatePublished - Nov 2019

Bibliographical note

Funding Information:
Dr. Garry has received grants from Regenerative Medicine Minnesota (RMM), the American Heart Association, the National Institutes of Health, and the Department of Defense. Both authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Keywords

  • cardiomyopathy
  • diastolic dysfunction
  • dystrophin
  • recombinant adeno-associated virus vectors
  • ribonucleotide reductase

PubMed: MeSH publication types

  • Editorial

Cite this